Top

Published in:

01-06-2011 | Current Status

Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery

Author: Mervyn Deitel

Published in: Obesity Surgery | Issue 6/2011

Abstract

Bariatric surgery provides resolution of co-morbidities of morbid obesity—importantly diabetes type 2. This is initiated by immediate postoperative decrease in intake or assimilation of glucose and is continued by the substantial loss of adipose tissue. Greater weight loss and greater resolution of type 2 diabetes occur after operations that provide rapid passage of nutrients to the hindgut, which likely results in beta-cell stimulation by incretins. Failure of resolution of the diabetes can result from lack of patient compliance, inadequate weight loss, longstanding uncontrolled diabetes, or when the diabetes is actually a type 1.

Sanderson I, Deitel M, Bojm MA. The handling of glucose and insulin response before and after weight loss with jejuno-ileal bypass. JPEN J Parenter Enteral Nutr. 1983;7:274–6.PubMedCrossRef

Deitel M, Sidhu PS, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese. Obes Surg. 1991;1:113–4. abst.

Sanderson I, Deitel M. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Ann Surg. 1974;179:387–94.PubMedCrossRef

Keith SJ, Mason EE, Scott DH, et al. Serum insulin and glucose levels, and insulin binding kinetics, in morbid and super obese patients undergoing vertical banded gastroplasty. Obes Surg. 1991;1:112. abst.

Gumbs AA, Modlin AM, Ballantyne GH. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg. 2005;15:462–73.PubMedCrossRef

Burstein R, Epstein Y, Charuzi I, et al. Glucose utilization in morbidly obese subjects before and after weight loss by gastric bypass operation. Int J Obes. 1995;19:558–61.

Mingrone G, DeGaetano A, Greco AV, et al. Reversability of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia. 1997;40:599–605.PubMedCrossRef

Türkoglu C, Duman BS, Güney D, et al. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature. Obes Surg. 2003;13:699–705.PubMedCrossRef

Näslund E, Backman L, Holst JJ, et al. Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg. 1998;8:253–60.PubMedCrossRef

10.

Mason EE. Gastric emptying controls type 2 diabetes mellitus (editorial). Obes Surg. 2007;17:853–5.PubMedCrossRef

11.

Valverde I, Puente J, Martin-Duce A, et al. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg. 2005;15:387–97.PubMedCrossRef

12.

le Roux CW, Dixon JB. Metabolic syndrome and type 2 diabetes: GLP-1 and other incretins. In: Deitel M, Gagner M, Dixon JB, et al., editors. Handbook of Obesity Surgery. Toronto: FD-Communications; 2010. p. 298–303.

13.

Reinehr T, Roth CL, Schernthaner G-H, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg. 2007;17:1571–7.PubMedCrossRef

14.

Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy—a “food-limiting” operation. Obes Surg. 2008;18:1251–6.PubMedCrossRef

15.

Karamanakos SN, Vagenes K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double-blind study. Ann Surg. 2008;247:401–7.PubMedCrossRef

16.

Shah S, Shah P, Todkar J, et al. Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6:152–7.PubMedCrossRef

17.

Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6:254–9.PubMedCrossRef

18.

DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6:249–53.PubMedCrossRef

19.

Hall TC, Pellen MGC, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–50.PubMedCrossRef

20.

Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis 2010 epub (In press).

21.

Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1004–10.CrossRef

22.

Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;229:316–23.CrossRef

23.

Deitel M. Surgery for diabetes at lower BMI: some caution (editorial). Obes Surg. 2008;18:1211–4.PubMedCrossRef

24.

Betterle C, Zanette F, Kawasaki E, et al. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first degree relatives. Diabetologia. 1983;26:431–6.

25.

Zimmet P, Turner R, McCarty D, et al. Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diab Care. 1999;22 Suppl 2:B59–64.

26.

Seisser J. Latent (slowly progressing) autoimmune diabetes in adults. Curr Diab Rep. 2008;8:94–100.CrossRef

27.

Landin-Olsson M. Latent autoimmune diabetes in adults. Ann NY Acad Sci. 2002;958:112–6. Apr.PubMedCrossRef

28.

Rosario PW, Reis JS, Fagundes TA, et al. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. Arq Bras Endocrinol Metabol. 2007;51:52–8.PubMedCrossRef

29.

Brophy S, Yderstraede K, Mauricio D, et al. Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diab Care. 2008;31:439–41.CrossRef

30.

Murao S, Kondo S, Ohashi J, et al. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)—5-year follow-up of the Ehime study. Diab Res Clin Pract. 2008;80:114–21.CrossRef

31.

Gagner M, Deitel M, Kalberer BA, et al. The Second International Consensus Summit for Sleeve Gastrectomy Mar 19–21, 2009. Surg Obes Relat Dis. 2009;5:476–85.PubMedCrossRef

32.

Czupryniak L, Wiszniewski M, Szymanski D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20:506–8.PubMedCrossRef

Title: Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery
Author: Mervyn Deitel
Publication date: 01-06-2011
Publisher: Springer-Verlag
Published in: Obesity Surgery / Issue 6/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-010-0329-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Update: Why Diabetes Does Not Resolve in Some Patients after Bariatric Surgery

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2011

Short Versus Long Roux-Limb Length in Roux-en-Y Gastric Bypass Surgery for the Treatment of Morbid and Super Obesity: a Systematic Review of the Literature

Understanding the Significance, Reasons and Patterns of Abnormal Vital Signs after Gastric Bypass for Morbid Obesity

Is Intestinal Gluconeogenesis a Key Factor in the Early Changes in Glucose Homeostasis Following Gastric Bypass?

Glycosaminoglycans of Abdominal Skin After Massive Weight Loss in Post-bariatric Female Patients

Efficacy of Low-Level Laser Therapy for Body Contouring and Spot Fat Reduction

Pregnancy After Bariatric Surgery: Implications for Mother and Newborn